Anand Reddi

Biotech and Global Health

[Anand Reddi @ReddiAnand]

Celebrating Joep Lange’s legacy and vision in the universal provision of HIV medicines. https://t.co/VlyxhH6j76

[Gilead Sciences @GileadSciences]

We helped open a new clinic in Ngokolo, Tanzania last month in honor of the late Joep Lange as part of our #HIV Test & Treat project. Here are highlights from the opening ceremony. #AIDS2018

[CLL Navigator @CLLNAVIGATOR]

Ever wondered how to read clinical trial charts & graphs? We break it down for you at https://t.co/OkNCOi1I4F so that you can be prepared for your next step.

[Anand Reddi @ReddiAnand]

https://t.co/XFGOlKCxji

[CLL Navigator @CLLNAVIGATOR]

CLL/SLL clinical trials evaluate the safety and effectiveness of potential new treatments for CLL.

Explore CLL/SLL clinical trials and education and prepare to talk with your healthcare team at https://t.co/OkNCOi1I4F.

#ClinicalTrials #CLLResearch #ResearchEducation

[BeOne Medicines @BeOneMedicines]

One quarter, many saves in motion ⚽

At BeOne, we know that progress in cancer does not happen in a single moment. It is built through many saves: the scientific decision that opens a new path, the clinical milestone that creates new possibility, the execution that helps innovative solutions reach more patients worldwide.

Our Q2 2026 results show that momentum in action. Our five key takeaways:

[CLL Navigator @CLLNAVIGATOR]

Managing CLL may also mean managing other health conditions, which may influence treatment discussions. Make sure every member of your healthcare team knows about your diagnoses, medications, supplements, and recent health changes.

Learn more at https://t.co/OkNCOi1I4F.

[Anand Reddi @ReddiAnand]

https://t.co/NQpXjaqDkW

[CLL Navigator @CLLNAVIGATOR]

BeOne Medicines & Blood Cancer United Announce Expanded Partnership to Advance Patient Support and Community.

We are proud to support the CLL/SLL patient and care partner community. Learn more at https://t.co/p6PzkrbK5K.

https://t.co/WFlF8xkUIm

[CLL Navigator @CLLNAVIGATOR]

Living with CLL or SLL? Find favorite recipes at https://t.co/OohTaAgCyX #CLLAwareness #HealthyEating #CancerNutrition

[CLL Navigator @CLLNAVIGATOR]

Considering CLL/SLL treatment? Use our questions to discuss side effects with your doctor. Visit https://t.co/BKKKtFgusL.
#CLLTreatment #SLLTreatment

[CLL Navigator @CLLNAVIGATOR]

When deciding on a course of treatment for #CLL, the numbers behind the treatment matter. Know what to ask. Visit https://t.co/BKKKtFgusL for resources. #CLLTreatment #PatientEducation #BloodCancer

[BeOne Medicines @BeOneMedicines]

Cancer is too complex to navigate alone. We’re introducing CLL Navigator™ - a digital hub for trusted education, practical tools, and peer support. Built in partnership with the CLL community, we’re working to empower patients and caregivers with clarity and connection.

Learn more: https://t.co/L1SLwCCoTy

#BeOneVoice

[BeOne Medicines @BeOneMedicines]

At #EHA2026, we’re sharing new long- term data in patients aged 80 and older – a population often underrepresented in CLL clinical trials despite the disease predominantly affecting older adults.

Hear from Dany Habr, M.D., our Head of Medical Affairs, North America & International Markets, on why these findings matter for clinical practice.

Learn more about BeOne at EHA: https://t.co/WYhZNUb0st

#FromFloorToFeed

[CLL Navigator @CLLNAVIGATOR]

Because CLL is chronic, ask your doctor about long-term treatment outcomes. Not sure what to ask? Visit https://t.co/BKKKtFgusL for resources.
#CLL #ChronicLymphocyticLeukemia #CLLTreatment #PatientResources #LongTermCare #CLLNavigator

[CLL Navigator @CLLNAVIGATOR]

“https://t.co/BKKKtFgusL is thoughtful, well-structured, and easily accessible. In particular, I loved the easy integration of the mental and emotional health components of the patient experience” - Geoff, CLL Patient

[BeOne Medicines @BeOneMedicines]

1 day to go. #ASCO26 kicks off tomorrow, and we’re ready to be immersed in the conversation. With 24 abstracts across hematology and solid tumors, we’ll be sharing new data and connecting with experts to improve patient care. Visit us at Booth 27017 if you’re in Chicago.

Learn more at: https://t.co/19SpNCzZyf

#BeOneAtASCO

[BeOne Medicines @BeOneMedicines]

In @USATODAY, we share where the future of CLL is heading and how long-term data is raising the bar. CLL progress has been years in the making, and now shows a meaningful shift from limited options to targeted therapies toward more durable disease control.

Learn more: https://t.co/icZ5KDgdQ0

#BeOneInnovator #BeOneAgainstCancer #ASCO26

[CLL Navigator @CLLNAVIGATOR]

Looking for clear information about CLL? Explore resources that can help you better understand the condition.
#CLL

[Eric Topol @EricTopol]

We've written about AI-induced physician deskilling that has already surfaced
https://t.co/iMy6zyWnhZ @tberzin
AI-induced never-skilling among newly trained doctors, while not yet proven, is a serious concern that needs to be addressed @NatureMedicine @nliulab
https://t.co/yov3YvsGti

[Bob Wachter @Bob_Wachter]

The AI backlash is growing – from graduating seniors to the Pope. Can healthcare, where optimism is warranted, insulate itself? I doubt it.
My new Substack: the backlash and healthcare, and why AI's titans should talk more about this (and less about AGI).
https://t.co/QcvIPkOCWw